Table 1.
Patient demographics, indication for HPN, catheter type and HPN macronutrient intake
| Demographics | |
|---|---|
| Number of patients | 101 |
| Female | 63 (62.4%) |
| Age at starting HPN (years) | 50 (range 28–87) |
| BMI (kg/m2) | 22.6 (range 12.7–43.9) |
| Days of observation (days) | 65 (range 2–1045) |
| Number of HPN infusion days (days) | 47 (range 2–921) |
| Primary indication for HPN; number and (% of total group) | |
| Intestinal fistula | 29 (28.7%) |
| Post-operation bowel dysfunction | 15 (14.9%) |
| Pancreatitis | 14 (13.9%) |
| Short bowel syndrome | 10 (9.9%) |
| Bowel obstruction | 10 (9.9%) |
| Cancer | 5 (4.9%) |
| Malnutrition/malabsorption | 4 (3.9%) |
| Other intestinal failure indications a | 14 (13.9%) |
| Catheter type; number and (% of total 196 catheters) | |
| PICC | 123 (62.8%) |
| Hickman® catheter | 51 (26.0%) |
| Subcutaneous port | 12 (6.1%) |
| Other catheter types b | 10 (5.1%) |
| Total calories, dextrose and lipid administered in HPN | |
| Total calories (kcal/kg BW/day) | 24 (range: 10 to 41) |
| Dextrose (g/kg BW/day) | 3.04 (range: 0.99 to 6.55) |
| Lipids (g/kg BW/day) | 0.79 (range: 0.07 to 1.82) |
Data presented as median and % of total study group, range or total number as indicated during the period of observation for each subject.
BW, body weight; BMI, body mass index; HPN, home parenteral nutrition; PICC, peripherally-inserted central venous catheter
a
Crohn’s disease (n=2); chronic nausea and vomiting (n=2); failure to thrive (n=2); radiation enteritis (n=1); gastroparesis (n=2); high ileostomy output (n=1); cholangitis (n=1); gastro-esophageal junction perforation (n=1); severe dysphagia (n=1); Gardner’s syndrome (n=1).
b
Groshong® catheter (n=5); tunneled central venous catheter (n=4); vascath (n=1).